Gambogic Acid
CAS No. 2752-65-0
Gambogic Acid( B-Guttiferrin | Beta-Guttiferrin | Beta-Guttilactone )
Catalog No. M17464 CAS No. 2752-65-0
Gambogic Acid ( EC50=0.78-1.64 uM) activates caspases. Gambogic Acid competitively suppresses Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 98 | In Stock |
|
| 25MG | 235 | In Stock |
|
| 50MG | 451 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGambogic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionGambogic Acid ( EC50=0.78-1.64 uM) activates caspases. Gambogic Acid competitively suppresses Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1.
-
DescriptionGambogic acid is a xanthonoid that is derived from the brownish or orange resin from Garcinia hanburyi. This natural chemical has shown promising antitumor activity in clinical trials. Gambogic acid inhibits cell proliferation, angiogenesis and metastasis. Gambogic acid is currently in clinical trials in China.
-
In Vitro——
-
In Vivo——
-
SynonymsB-Guttiferrin | Beta-Guttiferrin | Beta-Guttilactone
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorBfl-1| Mcl-1| Bcl-2| Bcl-B| Bcl-w
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number2752-65-0
-
Formula Weight628.75
-
Molecular FormulaC38H44O8
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL 159.05 mM; H2O : < 0.1 mg/mL
-
SMILES[C@]123C4(OC(C2C[C@@H](C=C1C(=O)c1c(O3)c(c2c(c1O)C=CC(O2)(CCC=C(C)C)C)CC=C(C)C)C4=O)(C)C)C/C=C(/C(=O)O)\C
-
Chemical Name(Z)-4-((1S,3aR,5S,11R,14aS)-8-hydroxy-2,2,11-trimethyl-13-(3-methylbut-2-en-1-yl)-11-(4-methylpent-3-en-1-yl)-4,7-dioxo-2,3a,4,5,7,11-hexahydro-1H-1,5-methanofuro[3,2-g]pyrano[3,2-b]xanthen-3a-yl)-2-methylbut-2-enoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhai D, et al. Mol Y Ther, 2008, 7(6), 1639-1646.
molnova catalog
related products
-
Volociximab
Volociximab (M200) is an IgG4 monoclonal antibody targeting the α5β1 integrin , with antiangiogenic, antitumor and anticancer activity, inhibits the growth of rabbit VX2 tumors and is used to study solid tumors.
-
GSK-3008348 hydrochl...
GSK-3008348 hydrochloride is a novel potent, selective integrin αvβ6 antagonist for the treatment of idiopathic pulmonary fibrosis (IPF).
-
BMS-688521
BMS-688521 BMS-688521 is an orally active and potent inhibitor of LFA-1/ICAM interaction, a small molecule antagonist of leukocyte function-associated antigen-1 (LFA-1), with potential anti-inflammatory activity.
Cart
sales@molnova.com